Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravindra K Gupta

Showing results (1-10 of 136) with videos related to

Pageof 14
Sort By:
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|June 24, 2006
Further escalation of the global HIV/AIDS epidemic in 2005 but one million patients on antiretroviral therapyRavindra K Gupta
The Lancet. HIV|January 7, 2023
We should not stop considering HIV drug resistance testing at failure of first-line antiretroviral therapyRami Kantor, Ravindra K Gupta
Viruses|October 14, 2011
Ultra structural characterisation of tetherin - a protein capable of preventing viral release from the plasma membraneRavindra K Gupta, Greg J Towers
Cell Host & Microbe|November 18, 2009
A tail of Tetherin: how pandemic HIV-1 conquered the worldRavindra K Gupta, Greg J Towers
Science (New York, N.Y.)|December 23, 2021
COVID-19 vaccine breakthrough infectionsRavindra K Gupta, Eric J Topol
Current Opinion in Infectious Diseases|May 2, 2009
Management of paediatric HIV-1 resistanceRavindra K Gupta, Diana M Gibb, Deenan Pillay
Current Opinion in Infectious Diseases|October 25, 2013
Macrophages: the neglected barrier to eradicationSarah A Watters, Petra Mlcochova, Ravindra K Gupta
Emerging Infectious Diseases|August 6, 2008
Bacterial pneumonia and pandemic influenza planningRavindra K Gupta, Robert George, Jonathan S Nguyen-Van-Tam
Cell Reports|March 27, 2020
TLR4-Mediated Pathway Triggers Interferon-Independent G0 Arrest and Antiviral SAMHD1 Activity in MacrophagesPetra Mlcochova, Helena Winstone, Lorena Zuliani-Alvarez, et al.
Wellcome Open Research|October 14, 2022
Point of care SARS-CoV-2 nucleic acid testing in schools improves school attendanceDami A Collier, Rachel Bousfield, Effrossyni Gkrania-Klotsas, et al.
Pageof 14

Showing results (1-10 of 136) with videos related to

Sort By:
Pageof 14
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|June 24, 2006
Further escalation of the global HIV/AIDS epidemic in 2005 but one million patients on antiretroviral therapyRavindra K Gupta
The Lancet. HIV|January 7, 2023
We should not stop considering HIV drug resistance testing at failure of first-line antiretroviral therapyRami Kantor, Ravindra K Gupta
Viruses|October 14, 2011
Ultra structural characterisation of tetherin - a protein capable of preventing viral release from the plasma membraneRavindra K Gupta, Greg J Towers
Cell Host & Microbe|November 18, 2009
A tail of Tetherin: how pandemic HIV-1 conquered the worldRavindra K Gupta, Greg J Towers
Science (New York, N.Y.)|December 23, 2021
COVID-19 vaccine breakthrough infectionsRavindra K Gupta, Eric J Topol
Current Opinion in Infectious Diseases|May 2, 2009
Management of paediatric HIV-1 resistanceRavindra K Gupta, Diana M Gibb, Deenan Pillay
Current Opinion in Infectious Diseases|October 25, 2013
Macrophages: the neglected barrier to eradicationSarah A Watters, Petra Mlcochova, Ravindra K Gupta
Emerging Infectious Diseases|August 6, 2008
Bacterial pneumonia and pandemic influenza planningRavindra K Gupta, Robert George, Jonathan S Nguyen-Van-Tam
Cell Reports|March 27, 2020
TLR4-Mediated Pathway Triggers Interferon-Independent G0 Arrest and Antiviral SAMHD1 Activity in MacrophagesPetra Mlcochova, Helena Winstone, Lorena Zuliani-Alvarez, et al.
Wellcome Open Research|October 14, 2022
Point of care SARS-CoV-2 nucleic acid testing in schools improves school attendanceDami A Collier, Rachel Bousfield, Effrossyni Gkrania-Klotsas, et al.
Pageof 14